NDC 70436-0101-09
tetrabenazine 12.5 mg/1 TABLET
Available — 2-Day Shipping
NDC
70436-0101-09
Generic Name
tetrabenazine
Brand Name
tetrabenazine
Strength
12.5 mg/1
Dosage Form
TABLET
Route
ORAL
Package Size
—
Labeler
Slate Run Pharmaceuticals, LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Tetrabenazine tablets are indicated for the treatment of chorea associated with Huntington’s disease. Tetrabenazine tablets are a vesicular monoamine transporter 2 (VMAT) inhibitor indicated for the treatment of chorea associated with Huntington’s disease. (1)
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All tetrabenazine Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 70436-0101-09 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).